Valuation: Shenzhen Lifotronic Technology Co., Ltd.

Capitalization 5.51B 811M 693M 635M 600M 1.11B 77.66B 1.12B 7.56B 2.94B 36.85B 3.04B 2.98B 128B P/E ratio 2026 *
23.2x
P/E ratio 2027 * 19.5x
Enterprise value 5.51B 811M 693M 635M 600M 1.11B 77.66B 1.12B 7.56B 2.94B 36.85B 3.04B 2.98B 128B EV / Sales 2026 *
4.49x
EV / Sales 2027 * 3.89x
Free-Float
47.71%
Yield 2026 *
3.65%
Yield 2027 * -
1 day+0.23%
1 week-1.46%
Current month-1.46%
1 month+2.63%
3 months-6.20%
6 months-8.99%
Current year-0.92%
1 week 12.76
Extreme 12.76
13.19
1 month 12.41
Extreme 12.41
13.19
Current year 12.06
Extreme 12.06
14.56
1 year 12.06
Extreme 12.06
14.88
3 years 12.06
Extreme 12.06
27.48
5 years 12.02
Extreme 12.02
32.35
10 years 12.02
Extreme 12.02
40.96
Manager TitleAgeSince
Chief Executive Officer 57 30/10/2017
Chief Administrative Officer 57 01/11/2020
Director of Finance/CFO 60 30/10/2017
Director TitleAgeSince
Chairman 58 30/10/2017
Director/Board Member 57 30/10/2017
Director/Board Member 57 30/10/2017
Change 5d. change 1-year change 3-years change Capi.($)
+0.23%-1.46%-1.53%-48.81% 809M
-2.16%+6.05%+136.53%+250.77% 13.25B
+1.15%+5.07%-36.68%-23.95% 10.21B
+0.37%+11.96%+22.17%-2.78% 6.27B
+1.25%+4.00%-5.69%-5.53% 5.73B
-13.37%-23.89% - - 4.74B
+4.45%+6.01%+101.87%+95.29% 4.6B
+3.31%+12.22%-26.99%-32.85% 4.24B
-0.81%+2.72%-12.51%-40.01% 2.92B
-1.12%-9.15%+114.09%-61.61% 2.66B
Average -0.69%+3.08%+32.36%+14.50% 5.54B
Weighted average by Cap. -0.77%+5.46%+42.62%+59.36%

Financials

2026 *2027 *
Net sales 1.23B 181M 154M 141M 134M 247M 17.29B 249M 1.68B 655M 8.21B 678M 664M 28.52B 1.42B 209M 178M 163M 154M 286M 19.97B 287M 1.94B 757M 9.48B 783M 767M 32.94B
Net income 238M 35.1M 29.98M 27.47M 25.97M 48.09M 3.36B 48.34M 327M 127M 1.59B 132M 129M 5.54B 282M 41.6M 35.52M 32.55M 30.77M 56.98M 3.98B 57.28M 388M 151M 1.89B 156M 153M 6.57B
Net Debt - -
Logo Shenzhen Lifotronic Technology Co., Ltd.
Shenzhen Lifotronic Technology Co Ltd is a China-based company mainly engaged in the research, development, manufacturing and marketing of medical devices. The Company focuses on the development and technological innovation of treatment and rehabilitation equipment, in vitro diagnostic equipment and supporting detection reagents. The Company's products mainly include wound and skin treatment products, perioperative and intensive care products, pain and rehabilitation treatment products and in vitro diagnostic products. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
1,670
Date Price Change Volume
12/05/26 12.86 ¥ +0.23% 1,861,680
12/05/26 12.83 ¥ -2.58% 2,937,745
11/05/26 13.17 ¥ +1.15% 3,040,017
08/05/26 13.02 ¥ +0.62% 2,453,798
07/05/26 12.94 ¥ +0.08% 2,243,433
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.86CNY
Average target price
14.68CNY
Spread / Average Target
+14.15%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688389 Stock